Clinical Trial Update: Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial (NCT04897009) is examining how neoadjuvant chemotherapy affects the peripheral blood immune phenotype in operable breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Invasive Breast Carcinoma | Status: ACTIVE_NOT_RECRUITING